Sprint Through Real-Time Promo Review

Agility benefits the entire value chain process, from basic research to clinical development, to ...

Words & Functionalities Matter: FDA Regulation of Consumer Software and Apps

Today, understanding whether digital health software or apps are actively regulated as medical devices ...

Progress Toward an Ethical Mindset

Everyone agrees that industry must move from rules- to values-based decision-making to ensure compliance ...

Talking About Your Pipeline

Ahead of commercialization, companies developing drugs and medical devices communicate about their pipeline products ...

Optimize Content Quality Globally

With anticipated launches of novel therapies and increasing sales for currently marketed prescription products, ...

Patient Experience Data and R&D

As the U.S. Food and Drug Administration (FDA) works to issue more guidance for ...

Technology Optimized Content

With the sheer volume and complexity of promotional materials today, it’s not surprising that ...

PFDD: A Game Changer?

The 21st Century Cures Act (Cures Act), which was passed by Congress, includes mandates ...

Pitfalls of Generic Drug Marketing

While many advertising agencies, companies, healthcare professionals, and consumers alike may not realize it, ...

That “Can Do” Attitude

Companies that are committed to patient-centered healthcare must incorporate the patient’s voice in all ...

Exhibit Displays: Beware the FDA

Companies attending large medical meetings to showcase innovative and marketed drug products alike should ...

The Trouble with Sampling in the State of Ohio

Have you ever heard about Ohio’s Terminal Distributor of Dangerous Drugs (TDDD) licenses? Before ...